CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $62,105
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-30 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Returned to the company | −5,000 | 76,968 | ||
| 2014-06-30 | BRADBURY DANIEL Director | Grant or award | +4,283 | 10,862 | ||
| 2014-06-30 | EASTHAM KARIN Director | Grant or award | +5,646 | 35,970 | ||
| 2014-06-30 | EASTHAM KARIN Director | Returned to the company | −2,500 | 33,470 | ||
| 2014-06-30 | Hofstaetter Thomas Director | Returned to the company | −2,500 | 26,564 | ||
| 2014-06-30 | Huh Hoyoung Director | Returned to the company | −10,000 | 119,119 | ||
| 2014-06-30 | Molineaux Susan Director | Grant or award | +4,089 | 17,056 | ||
| 2014-06-30 | Spiegel Robert J. Director | Grant or award | +4,478 | 49,027 | ||
| 2014-06-30 | Spiegel Robert J. Director | Returned to the company | −2,500 | 46,527 | ||
| 2014-05-29 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Sale | −3,379 | $2.10 | $7K | 81,968 |
| 2014-05-29 | BEHRS MELISSA KELLY EVP Portfolio & Alliance Mgmt | Sale | −4,826 | $2.10 | $10K | 143,015 |
| 2014-05-20 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | Huh Hoyoung Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | Hofstaetter Thomas Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-20 | BRADBURY DANIEL Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-05-09 | BRADBURY DANIEL Director | Purchase | +142,776 | $1.75 | $250K | 142,776 |
| 2014-04-01 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Sale | −7,435 | $2.13 | $16K | 85,347 |
Page 19 of 20 · 396 trades